397 related articles for article (PubMed ID: 33039404)
41. Cenicriviroc, a cytokine receptor antagonist, potentiates all-trans retinoic acid in reducing liver injury in cholestatic rodents.
Yu D; Cai SY; Mennone A; Vig P; Boyer JL
Liver Int; 2018 Jun; 38(6):1128-1138. PubMed ID: 29356312
[TBL] [Abstract][Full Text] [Related]
42. Telmisartan plus propranolol improves liver fibrosis and bile duct proliferation in the PSC-like Abcb4-/- mouse model.
Mende S; Schulte S; Strack I; Hunt H; Odenthal M; Pryymachuck G; Quasdorff M; Demir M; Nierhoff D; Dienes HP; Goeser T; Steffen HM; Töx U
Dig Dis Sci; 2013 May; 58(5):1271-81. PubMed ID: 23247798
[TBL] [Abstract][Full Text] [Related]
43. Novel Aspects in the Management of Cholestatic Liver Diseases.
Chazouillères O
Dig Dis; 2016; 34(4):340-6. PubMed ID: 27170387
[TBL] [Abstract][Full Text] [Related]
44. Keratin 7 expression in hepatic cholestatic diseases.
Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
[TBL] [Abstract][Full Text] [Related]
45. Colesevelam attenuates cholestatic liver and bile duct injury in
Fuchs CD; Paumgartner G; Mlitz V; Kunczer V; Halilbasic E; Leditznig N; Wahlström A; Ståhlman M; Thüringer A; Kashofer K; Stojakovic T; Marschall HU; Trauner M
Gut; 2018 Sep; 67(9):1683-1691. PubMed ID: 29636383
[TBL] [Abstract][Full Text] [Related]
46. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice.
Fickert P; Fuchsbichler A; Wagner M; Zollner G; Kaser A; Tilg H; Krause R; Lammert F; Langner C; Zatloukal K; Marschall HU; Denk H; Trauner M
Gastroenterology; 2004 Jul; 127(1):261-74. PubMed ID: 15236191
[TBL] [Abstract][Full Text] [Related]
47. Organic Anion Transporting Polypeptide (OATP) 1B3 is a Significant Transporter for Hepatic Uptake of Conjugated Bile Acids in Humans.
Pan Q; Zhu G; Xu Z; Zhu J; Ouyang J; Tong Y; Zhao N; Zhang X; Cheng Y; Zhang L; Tan Y; Li J; Zhang C; Chen W; Cai SY; Boyer JL; Chai J
Cell Mol Gastroenterol Hepatol; 2023; 16(2):223-242. PubMed ID: 37146714
[TBL] [Abstract][Full Text] [Related]
48. The inhibition of NFкB signaling and inflammatory response as a strategy for blunting bile acid-induced hepatic and renal toxicity.
Ahmadi A; Niknahad H; Li H; Mobasheri A; Manthari RK; Azarpira N; Mousavi K; Khalvati B; Zhao Y; Sun J; Zong Y; Ommati MM; Heidari R
Toxicol Lett; 2021 Oct; 349():12-29. PubMed ID: 34089816
[TBL] [Abstract][Full Text] [Related]
49. Early growth response factor-1 is critical for cholestatic liver injury.
Kim ND; Moon JO; Slitt AL; Copple BL
Toxicol Sci; 2006 Apr; 90(2):586-95. PubMed ID: 16423862
[TBL] [Abstract][Full Text] [Related]
50. Nerve growth factor induced farnesoid X receptor upregulation modulates autophagy flux and protects hepatocytes in cholestatic livers.
Tsai MS; Lee HM; Huang SC; Sun CK; Chiu TC; Chen PH; Lin YC; Hung TM; Lee PH; Kao YH
Arch Biochem Biophys; 2020 Mar; 682():108281. PubMed ID: 32001246
[TBL] [Abstract][Full Text] [Related]
51. IL-17A synergistically enhances bile acid-induced inflammation during obstructive cholestasis.
O'Brien KM; Allen KM; Rockwell CE; Towery K; Luyendyk JP; Copple BL
Am J Pathol; 2013 Nov; 183(5):1498-1507. PubMed ID: 24012680
[TBL] [Abstract][Full Text] [Related]
52. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1.
Zhuang Y; Ortega-Ribera M; Thevkar Nagesh P; Joshi R; Huang H; Wang Y; Zivny A; Mehta J; Parikh SM; Szabo G
Hepatology; 2024 Apr; 79(4):752-767. PubMed ID: 37725754
[TBL] [Abstract][Full Text] [Related]
53. Conditional loss of geranylgeranyl diphosphate synthase alleviates acute obstructive cholestatic liver injury by regulating hepatic bile acid metabolism.
Jia WJ; Tang QL; Jiang S; Sun SQ; Xue B; Qiu YD; Li CJ; Mao L
FEBS J; 2020 Aug; 287(15):3328-3345. PubMed ID: 31905247
[TBL] [Abstract][Full Text] [Related]
54. Intestinal dysbiosis augments liver disease progression via NLRP3 in a murine model of primary sclerosing cholangitis.
Liao L; Schneider KM; Galvez EJC; Frissen M; Marschall HU; Su H; Hatting M; Wahlström A; Haybaeck J; Puchas P; Mohs A; Peng J; Bergheim I; Nier A; Hennings J; Reißing J; Zimmermann HW; Longerich T; Strowig T; Liedtke C; Cubero FJ; Trautwein C
Gut; 2019 Aug; 68(8):1477-1492. PubMed ID: 30872395
[TBL] [Abstract][Full Text] [Related]
55. Serotonin protects mouse liver from cholestatic injury by decreasing bile salt pool after bile duct ligation.
Jang JH; Rickenbacher A; Humar B; Weber A; Raptis DA; Lehmann K; Stieger B; Moritz W; Soll C; Georgiev P; Fischer D; Laczko E; Graf R; Clavien PA
Hepatology; 2012 Jul; 56(1):209-18. PubMed ID: 22290718
[TBL] [Abstract][Full Text] [Related]
56. Nuclear Translocation of RELB Is Increased in Diseased Human Liver and Promotes Ductular Reaction and Biliary Fibrosis in Mice.
Elßner C; Goeppert B; Longerich T; Scherr AL; Stindt J; Nanduri LK; Rupp C; Kather JN; Schmitt N; Kautz N; Breuhahn K; Ismail L; Heide D; Hetzer J; García-Beccaria M; Hövelmeyer N; Waisman A; Urbanik T; Mueller S; Gdynia G; Banales JM; Roessler S; Schirmacher P; Jäger D; Schölch S; Keitel V; Heikenwalder M; Schulze-Bergkamen H; Köhler BC
Gastroenterology; 2019 Mar; 156(4):1190-1205.e14. PubMed ID: 30445013
[TBL] [Abstract][Full Text] [Related]
57. A common variant in the hepatobiliary phospholipid transporter ABCB4 modulates liver injury in PBC but not in PSC: prospective analysis in 867 patients.
Kruk B; Milkiewicz M; Raszeja-Wyszomirska J; Milkiewicz P; Krawczyk M
Orphanet J Rare Dis; 2022 Nov; 17(1):419. PubMed ID: 36397154
[TBL] [Abstract][Full Text] [Related]
58. Nuclear factor of activated T cells regulates osteopontin expression in arterial smooth muscle in response to diabetes-induced hyperglycemia.
Nilsson-Berglund LM; Zetterqvist AV; Nilsson-Ohman J; Sigvardsson M; González Bosc LV; Smith ML; Salehi A; Agardh E; Fredrikson GN; Agardh CD; Nilsson J; Wamhoff BR; Hultgårdh-Nilsson A; Gomez MF
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):218-24. PubMed ID: 19965778
[TBL] [Abstract][Full Text] [Related]
59. β-Catenin regulation of farnesoid X receptor signaling and bile acid metabolism during murine cholestasis.
Thompson MD; Moghe A; Cornuet P; Marino R; Tian J; Wang P; Ma X; Abrams M; Locker J; Monga SP; Nejak-Bowen K
Hepatology; 2018 Mar; 67(3):955-971. PubMed ID: 28714273
[TBL] [Abstract][Full Text] [Related]
60. Kinetics of hepatic bile acid handling in cholestatic liver disease: effect of ursodeoxycholic acid.
Jazrawi RP; de Caestecker JS; Goggin PM; Britten AJ; Joseph AE; Maxwell JD; Northfield TC
Gastroenterology; 1994 Jan; 106(1):134-42. PubMed ID: 8276175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
